Back to News
Market Impact: 0.2

MDT Factor-Based Stock Analysis

MDTNDAQ
Company FundamentalsAnalyst InsightsHealthcare & BiotechCapital Returns (Dividends / Buybacks)Market Technicals & FlowsInvestor Sentiment & Positioning
MDT Factor-Based Stock Analysis

Validea's guru fundamental report assesses Medtronic PLC (MDT) at 75% using the Pim van Vliet Multi-Factor Investor model, which prioritizes low volatility, strong momentum, and high net payout yields. While the large-cap medical equipment stock passes market cap and standard deviation criteria, it exhibits 'neutral' performance in momentum and net payout yield, leading to a 'fail' on final rank. This places MDT just below the 80% threshold required for strategic interest based on this specific low-volatility, factor-based approach.

Analysis

Medtronic PLC (MDT) scored 75% on Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy prioritizing low volatility, strong momentum, and high net payout yield. This score falls below the 80% threshold that typically indicates strategic interest. The analysis reveals a mixed profile for the large-cap medical equipment firm. MDT successfully passes the model's criteria for market capitalization and standard deviation, confirming its character as a low-volatility stock, which is a foundational element of the van Vliet approach. However, the stock received only a 'NEUTRAL' rating on two key performance drivers: 'Twelve Minus One Momentum' and 'Net Payout Yield'. This neutrality in recent price performance and shareholder returns ultimately led to a 'FAIL' on the model's final rank, suggesting that while MDT offers stability, it currently lacks the combined momentum and yield characteristics sought by this specific quantitative strategy for outperformance.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo